Mayo study shows drug slows stomach emptying, may individualize obesity treatment
ROCHESTER, Minn. ??Liraglutide injection, a prescription medication used to treat type-2 diabetes and obesity is associated with marked slowing of stomach emptying and is an effective weight loss therapy. These are the findings of a randomized, double-blind, placebo-controlled study by Mayo Clinic researchers published today in The Lancet Gastroenterology& Hepatology. ?Our paper shows that [...]
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news
More News: Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Gastroenterology | Hospital Management | Obesity | Study | Victoza | Weight Loss